The Georgia Cancer Center newsroom features all of the latest news, publications and media coverage for the cancer center.
May 11, 2023
The drugs are called HDAC inhibitors, and the investigators have early evidence one can reactivate after birth the gene that produces fetal hemoglobin, which cannot sickle.
May 08, 2023
The Georgia Cancer Center Pharmacogenomics Program (CaPP) has launched its pharmacogenomics testing services for Georgia Cancer Center patients and oncologists. Pharmacogenomics employs genetic sequence alterations in drug metabolism genes to predict toxicity. These genetic tests are done to measure changes in genes that make proteins that metabolize common chemotherapy drugs. If a patient has […]
On deadline? Call (706) 799-8841 to reach the Communications and Media Relations coordinator for the Georgia Cancer Center.
For other questions, contact:
706-721-9176
chrcurry@augusta.edu
